Research and analysis

Investigation of SARS-CoV-2 variants: technical briefings

Technical briefing documents on novel SARS-CoV-2 variants.

Applies to England

Documents

Technical briefing 55: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 54: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 53: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 52

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 52: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 51

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 51: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 50

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 50: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 49

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 49: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 48

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 48: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 47

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 47: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 46

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 46: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 45

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 45: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 44

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 44: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 43

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 43: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 42

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 42: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 41: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 41

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 40

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 40: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 39

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 39: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 38

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 38: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 37

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 37: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 36

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 36: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 35

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 35: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 34

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 34: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Omicron VOC-21NOV-01 (B.1.1.529) technical briefing: hospitalisation and vaccine effectiveness

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Omicron VOC-21NOV-01 (B.1.1.529) technical briefing: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 33

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 33: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 32

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 32: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 31

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 31: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: Omicron VOC-21NOV-01 (B.1.1.529) update on cases, S gene target failure and risk assessment

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Variants of concern Omicron update: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 30

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 30: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 29

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 29: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 28

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 28: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 27

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 27: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 26

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 26: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 25

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 25: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 24

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Technical briefing 24: underlying data

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Technical briefing documents and underlying data on novel SARS-CoV-2 variants.

Previous versions were published by Public Health England.

See daily overview and summary of case data for Omicron.

Updates to this page

Published 1 October 2021
Last updated 22 September 2023 + show all updates
  1. Added technical briefing 55 and underlying data spreadsheet.

  2. Added technical briefing 54 and underlying data spreadsheet.

  3. Corrected table 2 title in technical briefing 53.

  4. Corrected data in table 1 of technical briefing 53.

  5. Added technical briefing 53 and underlying data spreadsheet.

  6. Added technical briefing 52 and underlying data spreadsheet.

  7. Added technical briefing 51 and underlying data spreadsheet.

  8. Corrected section 4.1 of Technical briefing 50.

  9. Added technical briefing 50 and underlying data spreadsheet.

  10. Changed section 5.1 to part 6 in technical briefing 49.

  11. Added technical briefing 49 and underlying data spreadsheet.

  12. Added technical briefing 48 and underlying data spreadsheet.

  13. Minor correction to table 1b in technical briefings 45 and 46.

  14. Added latest technical briefing and underlying data.

  15. Correction to reporting of cases in England only in technical briefing 45.

  16. Added latest technical briefing and accompanying data.

  17. Added latest report and underlying data.

  18. Added technical briefing 44 and data spreadsheet.

  19. Updated technical briefing 43 with link to latest risk assessment.

  20. Added latest report and underlying data.

  21. Added latest report and underlying data.

  22. Added latest report and underlying data.

  23. Added latest weekly report and underlying data.

  24. Added latest report and underlying data.

  25. Added latest Technical Briefing and accompanying data.

  26. Added latest technical briefing and underlying data.

  27. Corrected data cut-off date to 7 February 2022 for technical briefing 36.

  28. Added latest technical briefing and underlying data.

  29. Added latest technical briefing and accompanying data.

  30. Updated link in technical briefing 34 to Oxford University and ONS study.

  31. A correction has been made to the summary and symptom analysis text due to an earlier error. The analysis and findings are unchanged.

  32. Added latest technical briefing and underlying data.

  33. Corrected next publication date of Omicron risk assessment in latest technical briefing.

  34. Added technical briefing on Omicron and underlying data.

  35. Added technical briefing 33.

  36. Updated information about the performance of diagnostic LFDs under 2.1 in Technical Briefing 32.

  37. Added latest Technical Briefing and underlying data.

  38. Omicron daily overview moved to new page and linked from details section.

  39. Added Omicron daily overview: 13 December 2021.

  40. Added latest technical briefing and underlying data.

  41. Added 'Omicron VOC-21NOV-01 (B.1.1.529) update on cases, S gene target failure and risk assessment' and underlying data.

  42. Added latest technical briefing and underlying data.

  43. Added latest technical briefing and accompanying data.

  44. Added technical briefing 28 and underlying data.

  45. Added technical briefing 27 and underlying data.

  46. Added technical briefing 26 and underlying data.

  47. Added latest Technical Briefing and underlying data.

  48. First published.

Sign up for emails or print this page